Severe malaria

Active Ingredient: Artesunate

Indication for Artesunate

Population group: only minors (0 - 18 years old) , adults (18 years old or older)
Therapeutic intent: Curative procedure

Artesunate is indicated for the initial treatment of severe malaria in adults and children.

Consideration should be given to official guidance on the appropriate use of antimalarial agents.

For this indication, competent medicine agencies globally authorize below treatments:

2.4 mg/kg at 0, 12 and 24 hours

For:

Dosage regimens

Intravenous, 2.4 milligrams artesunate per kilogram of body weight, once every 12 hours, 3 doses in total.

Detailed description

Initial treatment of severe malaria with artesunate should always be followed by a complete treatment course with appropriate oral antimalarial therapy.

Adults and children (birth to less than 18 years)

The recommended dose is 2.4 mg/kg (0.24 mL of reconstituted solution for injection per kg body weight) by intravenous (IV) injection at 0, 12 and 24 hours.

After at least 24 hours (3 doses) treatment with artesunate, patients unable to tolerate oral treatment may continue to receive intravenous treatment with 2.4 mg/kg once every 24 hours (from 48 hours after start of treatment).

Treatment with artesunate should be stopped when patients can tolerate oral treatment. After stopping artesunate, all patients should receive a complete treatment course of an appropriate oral combination antimalarial regimen.

Active ingredient

Artesunate

Artesunate is a semi-synthetic artemisinin derivative, indicated for the initial treatment of severe malaria in adults and children. The antimalarial mechanism of action of artesunate is generally thought to depend upon activation involving iron-mediated cleavage of the endoperoxide bridge of DHA to generate an unstable organic free radical followed by alkylation, where the free radical binds to malarial proteins leading to destruction of parasite membranes.

Read more about Artesunate

Related medicines

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner

Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.